HR-9048-119
Referred to the House Committee on Energy and Commerce.
Sponsored by Emanuel Cleaver (D-MO)
What it does
This bill would amend the Federal Food, Drug, and Cosmetic Act to classify gluten-containing grains—wheat, rye, barley, and their hybrids like triticale—as "major food allergens" alongside milk and other existing categories. Food manufacturers would need to comply with major allergen labeling requirements for these grains on products sold in interstate commerce starting 18 months after enactment.
Who benefits
People with celiac disease and gluten sensitivity (estimated 1-3 million with celiac disease, plus a larger number with non-celiac gluten sensitivity), who would gain clearer, standardized labeling to identify gluten-containing ingredients. Advocacy groups for celiac disease patients and allergists who treat these conditions would also benefit from more consistent labeling standards.
Who is hurt
Food manufacturers and packagers who would bear compliance costs for relabeling products and updating manufacturing/allergen-control processes, particularly smaller producers with less capacity to absorb these costs. Grain producers and bakeries could see indirect costs passed through the supply chain, and some products may see price increases to offset compliance expenses.
Supporters argue
Supporters argue that gluten-containing grains cause serious autoimmune reactions in people with celiac disease, and current labeling under the Food Allergen Labeling and Consumer Protection Act does not treat wheat consistently with rye and barley, creating gaps that leave sensitive consumers uncertain about hidden gluten sources. They contend that formal major-allergen status would standardize disclosure requirements industry-wide, similar to how milk, eggs, and peanuts are already treated, reducing accidental exposure and associated health complications.
Opponents argue
Opponents argue that wheat is already a recognized major allergen under existing law, so this bill mainly adds rye and barley, which have far smaller affected populations, and that the compliance costs and labeling changes may not be proportionate to the added public health benefit. They contend that manufacturers, especially smaller producers, would face new testing, supply-chain tracking, and relabeling costs during the 18-month transition, potentially raising prices without a correspondingly large increase in consumer protection.
Constitutional context
Congress regulates food labeling and manufacturing standards affecting interstate commerce under the Commerce Clause (Art. I, §8, cl. 3), consistent with the framework upheld in Wickard v. Filburn (1942) for federal regulation of goods moving in or affecting interstate commerce; this bill raises no novel constitutional question beyond that established authority.
Checks and balances
Congress would set the labeling requirement by statute, and the FDA would implement enforcement through existing rulemaking and inspection authority, with courts available to review agency actions under post-Loper Bright independent judicial review standards.
Historical precedent
The Food Allergen Labeling and Consumer Protection Act of 2004 established the original major food allergen labeling framework that this bill would amend.